- Home
- ARQT vs FULT Comparison
ARQT vs FULT Comparison
Compare ARQT & FULT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARQT | FULT |
|---|---|---|
| Founded | 2016 | 1882 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.5B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARQT | FULT |
|---|---|---|
| Price | $22.18 | $19.57 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $34.00 | $21.40 |
| AVG Volume (30 Days) | 1.2M | ★ 1.8M |
| Earning Date | 05-05-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 3.91% |
| EPS Growth | ★ 88.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $376,072,000.00 | N/A |
| Revenue This Year | $34.46 | $6.39 |
| Revenue Next Year | $29.77 | $5.52 |
| P/E Ratio | ★ N/A | $10.58 |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $11.86 | $14.33 |
| 52 Week High | $31.77 | $22.99 |
Technical Indicators
Market Signals| Indicator | ARQT | FULT |
|---|---|---|
| Relative Strength Index (RSI) | 37.45 | 35.98 |
| Support Level | $22.56 | $19.07 |
| Resistance Level | $27.26 | $19.97 |
| Average True Range (ATR) | 0.92 | 0.53 |
| MACD | -0.13 | -0.11 |
| Stochastic Oscillator | 22.56 | 21.56 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About FULT Fulton Financial Corporation
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.